What resources are available to facilitate your patient management?
2017 GOLD COPD guidelines update
The 2017 GOLD COPD guidelines focus on the role of long-acting muscarinic antagonists/long-acting beta2-agonists (LAMA/LABA) dual bronchodilation therapy in the management of patients with COPD, particularly GOLD B and GOLD D patients with severe breathlessness and/or exacerbations. The updated guidelines also detail the importance of choosing the correct inhaler for your patient, whilst reflecting the patient’s ability and overall preference. 1